Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions

NCT02277704 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

245

Enrollment

INDUSTRY

Sponsor class

Conditions

PTSD

Interventions

DRUG: TNX-102 SL
DRUG: Placebo

Sponsor

Tonix Pharmaceuticals, Inc.